In response to a number of late, repetitive bleeding episodes from the site of the 
| INTRODUC TI ON
Pancreas transplantation is the gold standard for treatment of type 1 diabetes mellitus with end-stage renal disease. It restores blood sugar homeostasis and stabilizes the course of secondary diabetic complications. 1, 2 Despite continuous improvements in surgical techniques and immunosuppressive regimens, pancreas transplantation remains challenging in terms of early as well as late postoperative complications. 3, 4 While thrombosis is the most frequent vascular complication in the early period after transplantation, hemorrhage, although less common, may be a life-threatening condition occurring early as well as late after transplantation. Primary causes for late bleeding episodes are fistulae (arterioenteric, arterioureteric, arteriocystic, or arteriovenous), pseudoaneurysms, invasive infections, as well as severe rejection episodes. [5] [6] [7] [8] [9] In addition to the vascular anastomoses, the enteric anastomoses are a potential source of bleeding in enterically drained pancreas grafts. [10] [11] [12] We herein investigate the late hemorrhagic episodes originating from the graft duodenal anastomosis. Bleeding from the anastomotic site was associated with hematochezia, hemodynamic instability and decrease in serum hemoglobin. Mean onset was 6.4(±2.8) years after transplantation. Bleeding was recurrent (mean 5.2 ± 2.6) and required 9(±2.5) interventions.
Hypervascularization, mucosal vulnerability, and bleeding at the site of the enteric anastomosis could be identified in all cases. In four patients, the enteric pancreas anastomosis was resected and a new duodenojejunostomy was performed. No pancreas graft loss occurred due to bleeding. In two patients, hepatic cirrhosis and portal hypertension were identified, one patient had a liver fibrosis as putative cause for the repetitive bleeding episodes. Late anastomotic hemorrhage is a rare but severe complication following pancreas transplantation. The treatment is challenging and includes endoscopy, interventional radiology, and surgery. Hepatic conditions with an increased portal pressure may be the underlying cause.
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| PATIENTS AND ME THODS
We retrospectively analyzed 379 consecutively performed pancreas Long-term anticoagulation consisted of acetyl salicylic acid daily in most patients related top reexisting conditions such as coronary heart and/or peripheral vascular disease. TA B L E 2 Detailed information about bleeding episodes, interventions and bleeding source (Table 3) . In all patients, acute rejection and infectious complications (CMV, invasive fungus) could be ruled out as underlying cause for the episodes (Table 4 observed. In the remaining two cases, the causes of the bleeding episodes remained unclear (Table 4 ).
| RE SULTS

| D ISCUSS I ON
Massive gastrointestinal hemorrhage after pancreas transplantation is rare but may be potentially life-threatening. They can be divided Whereas the term "early" is used for episodes which occur during the initial hospital stay or within the first 3 months after transplantation, "late" episodes are seen after the first 3 months but can also occur years after transplantation. 13 In the early postoperative pe- We herein summarize our experience with late recurrent bleeding complications from the enteric anastomosis site years after pancreas transplantation in five patients. In all cases, the pancreas allograft was functioning well at the time the complication occurred and remained unaffected by the hemorrhage and related interventions. With a multimodal approach including endoscopy, angiography, and surgery, the hemorrhage could eventually be controlled. As proposed by Yadav et al, treatment strategies should be adapted individually for each situation and should take in to account existing graft function. In case of loss of function, pancreatectomy should be considered immediately or after hemodynamic stabilization via endovascular (stenting, embolization) strategies. 4, 12, 26 When the pancreatic function is still present, strategies should be adapted to achieve allograft preservation in case of hemodynamic stability. 4 In two cases where bleeding recurred after surgery, hepatic cirrhosis was present and most likely a causal co-factor. We F I G U R E 2 Management algorithm for late gastrointestinal bleeding after pancreas transplantation. Therapeutic decisions are initially based on hemodynamic stability upon hospital admission. Due to the proximal localization of the duodenojejunostomy in our cohort, we primarily aim for endoscopic treatment in stable patients. Only in case of instability or unsuccessful endoscopic approach in stable patients an angio-CT scan should be performed in order to detect intervenable bleeding sources. If possible interventional radiology should be performed, if not a surgical approach should be considered and operative strategy should be adapted to the current pancreas graft function Drainage of the graft duodenum to the small intestine close to the duodenojejunal flexure is the preferred technique at our institution.
As endoscopists are always available, we primarily aim for endoscopic control of bleeding in stable patients. This is mostly facilitated via push enteroscopy using an enteroscope or pediatric colonoscope. 27 When the patient presents as unstable, endoscopic therapy is unsuccessful, or the source of bleeding is not visible, subsequent CT angiography followed by endovascular intervention is performed. In these cases, an iliac artery angiogram rather than visceral angiogram is of utmost im-
portance, yet both may be necessary. Surgery remains the last option and is only performed when endoscopy and interventional radiology fail ( Figure 2) .
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